Nuvalent (NUVL) Consolidated Net Income (2020 - 2026)

Nuvalent (NUVL) reported Consolidated Net Income of -$109.3 million for Q1 2026, down 29.2% on a YoY basis from -$154.3 million in Q1 2025, and up 7.95% quarter-over-quarter from -$118.7 million in Q4 2025.

Nuvalent (NUVL) Consolidated Net Income (2020 - 2026) Analysis & Trends

Nuvalent has reported Consolidated Net Income for 7 years, with the latest figure at -$109.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Consolidated Net Income fell 29.2% year-over-year to -$109.3 million; the trailing twelve-month figure through Mar 2026 stood at -$450.1 million (down 49.6% YoY), and the FY2025 full-year result was -$425.4 million, down 63.14% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at -$109.3 million, up from -$118.7 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$17.5 million in Q1 2022, with the low at -$122.4 million in Q3 2025.
  • Historically, Consolidated Net Income has averaged -$59.0 million across 5 years, with a median of -$44.5 million in 2024.
  • Annual changes were most pronounced in 2022 — Consolidated Net Income plunged 184.79% — and 2026, when it decreased 29.2%.
  • Nuvalent's Consolidated Net Income stood at -$26.1 million in 2022, then slumped by 46.62% to -$38.3 million in 2023, then sank by 95.24% to -$74.8 million in 2024, then plunged by 58.8% to -$118.7 million in 2025, then rose by 7.95% to -$109.3 million in 2026.
  • The last three Consolidated Net Income figures came in at -$109.3 million (Q1 2026), -$118.7 million (Q4 2025), and -$122.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.97 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -14.46 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -3.40 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.71 Bn 91.71 Bn - -56.48 Mn
10 Nuvalent 9.70 Bn 9.70 Bn - -109.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -109.28 Mn
Dec 31, 2025 -118.72 Mn
Sep 30, 2025 -122.44 Mn
Jun 30, 2025 -99.65 Mn
Mar 31, 2025 -84.58 Mn
Dec 31, 2024 -74.76 Mn
Sep 30, 2024 -84.35 Mn
Jun 30, 2024 -57.17 Mn
Mar 31, 2024 -44.48 Mn
Dec 31, 2023 -38.29 Mn
Sep 30, 2023 -33.65 Mn
Jun 30, 2023 -29.09 Mn
Mar 31, 2023 -25.19 Mn
Dec 31, 2022 -26.12 Mn
Sep 30, 2022 -19.72 Mn
Jun 30, 2022 -18.47 Mn
Mar 31, 2022 -17.55 Mn
Dec 31, 2021 -17.38 Mn
Sep 30, 2021 -12.43 Mn
Jun 30, 2021 -9.85 Mn